Meridiem Capital Partners LP
Position in CRL — Charles River Laboratories International, Inc.
CIK 2026798
DALLAS, TX
Position in CRL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$56,012,367
-$6,449,538 QoQ
Shares Held
246,979
-31.8% QoQ
Ownership
0.517%
of shares outstanding
% of Portfolio
2.58%
of 13F equity value
Holder Rank
#49
of 564 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Meridiem Capital Partners LP holds $354,215,795 across 10 Diagnostics & Research names. CRL ranks #3 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
537,437 | $102,370,999 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
50,157 | $64,076,069 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
This page
|
246,979 | $56,012,367 | |
| 4 | WAT |
Waters Corp /De/
|
99,260 | $37,226,470 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
144,630 | $27,945,408 | |
| 6 | RVTY |
Revvity, Inc.
|
193,094 | $21,483,638 | |
| 7 | GH |
Guardant Health, Inc.
|
97,088 | $14,566,112 | |
| 8 | QGEN |
Qiagen N.V.
|
369,740 | $14,456,834 |
All Filings in CRL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,012,367 | 246,979 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $62,461,905 | 362,098 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,507,500 | 132,883 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,025,266 | 70,467 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $18,212,758 | 120,034 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||